...
首页> 外文期刊>BJU international >Risk group stratification to predict recurrence after transurethral resection in Japanese patients with stage Ta and T1 bladder tumours: validation study on the European Association of Urology guidelines.
【24h】

Risk group stratification to predict recurrence after transurethral resection in Japanese patients with stage Ta and T1 bladder tumours: validation study on the European Association of Urology guidelines.

机译:日本Ta和T1期膀胱肿瘤患者经尿道切除术后的危险人群分层预测复发:欧洲泌尿外科协会指南的验证研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: * To validate the European Association of Urology (EAU) guidelines on risk group stratification to predict recurrence in Japanese patients with stage Ta and T1 bladder tumours. PATIENTS AND METHODS: * A cohort of 592 Japanese patients who were treated with transurethral resection (TUR) and histopathologically diagnosed with Ta and T1 urothelial carcinoma of the bladder were enrolled in this retrospective study. * The primary endpoint of the present study was recurrence-free survival, and the median follow-up duration was 37 months in recurrence-free survivors. RESULTS: * Multivariate Cox proportional hazards regression analysis showed that the Eastern Cooperative Oncology Group performance status (ECOG PS), prior recurrence rate, number of tumours and T category were independent predictors of time to recurrence (P < 0.05). According to the EAU guidelines for predicting recurrence, the vast majority of Japanese patients were classified into intermediate risk. * The intermediate-risk patients were further divided into intermediate-low-risk and intermediate-high-risk subgroups based on the European Organization for Research and Treatment of Cancer risk table, and a significant difference in the recurrence-free survival rates was found between these subgroups (P < 0.001). * It was also found that patients with high risk combined with intermediate-high risk had significantly poorer recurrence-free survival rates than those with low risk combined with intermediate-low risk (P < 0.001). CONCLUSIONS: * This is the first report on the ECOG PS as a potentially useful predictor for bladder tumour recurrence. * The risk group stratification of the EAU guidelines for recurrence might not be applicable to Japanese patients with Ta and T1 bladder tumours, but the subgroup classification of intermediate risk could be appropriate.
机译:目的:*验证欧洲泌尿外科协会(EAU)关于危险组分层的指南,以预测日本Ta和T1期膀胱肿瘤患者的复发情况。患者与方法:*这项纳入592例日本患者的研究对象为经尿道切除术(TUR)治疗并经组织病理学诊断为Ta和T1膀胱尿路上皮癌的患者。 *本研究的主要终点是无复发生存期,无复发生存期中位随访时间为37个月。结果:*多元Cox比例风险回归分析表明,东部合作肿瘤小组的表现状态(ECOG PS),既往复发率,肿瘤数目和T类别是复发时间的独立预测因子(P <0.05)。根据EAU预测复发的指南,绝大多数日本患者被分类为中等风险。 *根据欧洲癌症研究与治疗风险表,将中度风险患者进一步分为中度低风险和中度高风险亚组,发现无复发生存率之间存在显着差异这些亚组(P <0.001)。 *还发现,高风险合并中高风险的患者的无复发生存率显着低于低风险合并中低风险的患者(P <0.001)。结论:*这是关于ECOG PS作为膀胱肿瘤复发的潜在有用预测指标的首次报道。 * EAU复发指南的危险人群分层可能不适用于日本Ta和T1膀胱肿瘤患者,但中等危险的亚组分类可能是适当的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号